18414037	207	Palomero T	The role of the PTEN/AKT Pathway in NOTCH1-induced leukemia.	Cell cycle	2008	65
24486344	207	Zhang H	Salvianolic acid A protects RPE cells against oxidative stress through activation of Nrf2/HO-1 signaling.	Free radical biology and medicine	2014	29
27517753	207	Gong YQ	SC79 protects retinal pigment epithelium cells from UV radiation via activating Akt-Nrf2 signaling.	Oncotarget	2016	15
18434643	361	Matiello M	NMO-IgG predicts the outcome of recurrent optic neuritis.	Neurology	2008	58
19229993	361	Nicchia GP	Aquaporin-4 orthogonal arrays of particles are the target for neuromyelitis optica autoantibodies.	Glia	2009	55
22577216	361	Kitley J	Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan.	Brain 	2012	34
23623397	361	Pittock SJ	Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study.	The Lancet. Neurology	2013	53
26190071	717	van Breugel F	Mosquitoes Use Vision to Associate Odor Plumes with Thermal Targets.	Current biology 	2015	18
25069777	1000	Sareen D	Differentiation of human limbal-derived induced pluripotent stem cells into limbal-like epithelium.	Stem cells translational medicine	2014	23
17483097	1121	van den Hurk JA	L1 retrotransposition can occur early in human embryonic development.	Human molecular genetics	2007	65
24439297	1121	MacLaren RE	Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trial.	Lancet	2014	122
16505355	1270	Sieving PA	Ciliary neurotrophic factor (CNTF) for human retinal degeneration: phase I trial of CNTF delivered by encapsulated cell intraocular implants.	Proceedings of the National Academy of Sciences of the United States of America	2006	138
21087953	1270	Talcott KE	Longitudinal study of cone photoreceptors during retinal degeneration and in response to ciliary neurotrophic factor treatment.	Investigative ophthalmology and visual science	2011	77
21444807	1270	Zhang K	Ciliary neurotrophic factor delivered by encapsulated cell intraocular implants for treatment of geographic atrophy in age-related macular degeneration.	Proceedings of the National Academy of Sciences of the United States of America	2011	56
22182585	1270	Wen R	CNTF and retina.	Progress in retinal and eye research	2012	43
23618907	1270	Leibinger M	Interleukin-6 contributes to CNS axon regeneration upon inflammatory stimulation.	Cell death and disease	2013	31
23668681	1270	Birch DG	Randomized trial of ciliary neurotrophic factor delivered by encapsulated cell intraocular implants for retinitis pigmentosa.	American journal of ophthalmology	2013	34
11689488	1296	Biswas S	Missense mutations in COL8A2, the gene encoding the alpha2 chain of type VIII collagen, cause two forms of corneal endothelial dystrophy.	Human molecular genetics	2001	91
15914606	1296	Gottsch JD	Inheritance of a novel COL8A2 mutation defines a distinct early-onset subtype of fuchs corneal dystrophy.	Investigative ophthalmology and visual science	2005	65
20847286	1296	Jurkunas UV	Evidence of oxidative stress in the pathogenesis of fuchs endothelial corneal dystrophy.	The American journal of pathology	2010	57
23508240	1392	Macdonald K	Helping oxytocin deliver: considerations in the development of oxytocin-based therapeutics for brain disorders.	Frontiers in neuroscience	2013	30
14871913	1401	Seddon JM	Association between C-reactive protein and age-related macular degeneration.	JAMA	2004	95
15955978	1401	Seddon JM	Progression of age-related macular degeneration: prospective assessment of C-reactive protein, interleukin 6, and other cardiovascular biomarkers.	Archives of ophthalmology	2005	90
22294344	1401	Sibley CH	Sustained response and prevention of damage progression in patients with neonatal-onset multisystem inflammatory disease treated with anakinra: a cohort study to determine three- and five-year outcomes.	Arthritis and rheumatism	2012	44
24481424	1401	Klein R	Markers of inflammation, oxidative stress, and endothelial dysfunction and the 20-year cumulative incidence of early age-related macular degeneration: the Beaver Dam Eye Study.	JAMA ophthalmology	2014	31
24695951	1401	Simeone E	Immunological and biological changes during ipilimumab treatment and their potential correlation with clinical response and survival in patients with advanced melanoma.	Cancer immunology, immunotherapy 	2014	28
9390516	1406	Chen S	Crx, a novel Otx-like paired-homeodomain protein, binds to and transactivates photoreceptor cell-specific genes.	Neuron	1997	175
9390563	1406	Freund CL	Cone-rod dystrophy due to mutations in a novel photoreceptor-specific homeobox gene (CRX) essential for maintenance of the photoreceptor.	Cell	1997	122
15932940	1406	Palhan VB	Polyglutamine-expanded ataxin-7 inhibits STAGA histone acetyltransferase activity to produce retinal degeneration.	Proceedings of the National Academy of Sciences of the United States of America	2005	79
23132794	1406	Boucherie C	Brief report: self-organizing neuroepithelium from human pluripotent stem cells facilitates derivation of photoreceptors.	Stem cells	2013	30
9467006	1409	Litt M	Autosomal dominant congenital cataract associated with a missense mutation in the human alpha crystallin gene CRYAA.	Human molecular genetics	1998	114
18587492	1409	Devi RR	Crystallin gene mutations in Indian families with inherited pediatric cataract.	Molecular vision	2008	64
18285558	1432	Ali TK	Peroxynitrite mediates retinal neurodegeneration by inhibiting nerve growth factor survival signaling in experimental and human diabetes.	Diabetes	2008	61
18420487	1432	Busik JV	Hyperglycemia-induced reactive oxygen species toxicity to endothelial cells is dependent on paracrine mediators.	Diabetes	2008	75
20957344	1432	Ali TK	Diabetes-induced peroxynitrite impairs the balance of pro-nerve growth factor and nerve growth factor, and causes neurovascular injury.	Diabetologia	2011	44
22101332	1490	Fuchshofer R	The role of TGF-β in the pathogenesis of primary open-angle glaucoma.	Cell and tissue research	2012	58
24837142	1490	Brodowska K	The clinically used photosensitizer Verteporfin (VP) inhibits YAP-TEAD and human retinoblastoma cell growth in vitro without light activation.	Experimental eye research	2014	24
19270709	1499	Hong HS	A new role of substance P as an injury-inducible messenger for mobilization of CD29(+) stromal-like cells.	Nature medicine	2009	50
19893025	1499	Chen Y	Activation of the Wnt pathway plays a pathogenic role in diabetic retinopathy in humans and animal models.	The American journal of pathology	2009	55
9097971	1545	Stoilov I	Identification of three different truncating mutations in cytochrome P4501B1 (CYP1B1) as the principal cause of primary congenital glaucoma (Buphthalmos) in families linked to the GLC3A locus on chromosome 2p21.	Human molecular genetics	1997	147
24149323	1602	Yan W	Epigenetic regulation of DACH1, a novel Wnt signaling component in colorectal cancer.	Epigenetics	2013	26
17765963	1636	Patel A	Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial.	Lancet	2007	245
21544514	1636	Tseng CH	Diabetes and risk of bladder cancer: a study using the National Health Insurance database in Taiwan.	Diabetologia	2011	35
22409294	1906	Zhou J	Role of intravitreal inflammatory cytokines and angiogenic factors in proliferative diabetic retinopathy.	Current eye research	2012	33
23742177	1906	Flammer J	The primary vascular dysregulation syndrome: implications for eye diseases.	The EPMA journal	2013	42
25075228	1906	Konieczka K	Flammer syndrome.	The EPMA journal	2014	25
10487957	1950	Pflugfelder SC	Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjögren's syndrome keratoconjunctivitis sicca.	Current eye research	1999	103
18992869	1950	Lam H	Tear cytokine profiles in dysfunctional tear syndrome.	American journal of ophthalmology	2009	97
19747980	2006	Booij JC	The dynamic nature of Bruch's membrane.	Progress in retinal and eye research	2010	70
21683322	2200	Le Goff C	Mutations in the TGFβ binding-protein-like domain 5 of FBN1 are responsible for acromicric and geleophysic dysplasias.	American journal of human genetics	2011	35
12140558	2218	Michele DE	Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies.	Nature	2002	219
12140559	2218	Moore SA	Deletion of brain dystroglycan recapitulates aspects of congenital muscular dystrophy.	Nature	2002	140
11854116	2247	Simons M	Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial.	Circulation	2002	96
18220619	2247	Simó R	Angiogenic and antiangiogenic factors in proliferative diabetic retinopathy.	Current diabetes reviews	2006	75
20882530	2247	Hu Q	Memory in induced pluripotent stem cells: reprogrammed human retinal-pigmented epithelial cells show tendency for spontaneous redifferentiation.	Stem cells	2010	62
22085933	2247	Greber B	FGF signalling inhibits neural induction in human embryonic stem cells.	The EMBO journal	2011	51
24433355	2296	Ito YA	Genomics and anterior segment dysgenesis: a review.	Clinical and experimental ophthalmology	2014	23
15942192	2335	de Iongh RU	Transforming growth factor-beta-induced epithelial-mesenchymal transition in the lens: a model for cataract formation.	Cells, tissues, organs	2005	73
16384967	2335	Fleenor DL	TGFbeta2-induced changes in human trabecular meshwork: implications for intraocular pressure.	Investigative ophthalmology and visual science	2006	93
19875671	2335	Karamichos D	Human corneal fibrosis: an in vitro model.	Investigative ophthalmology and visual science	2010	49
19940066	2335	Pattabiraman PP	Mechanistic basis of Rho GTPase-induced extracellular matrix synthesis in trabecular meshwork cells.	American journal of physiology. Cell physiology	2010	45
22894573	2335	Stalmans P	Enzymatic vitreolysis with ocriplasmin for vitreomacular traction and macular holes.	The New England journal of medicine	2012	75
12457340	2697	Paznekas WA	Connexin 43 (GJA1) mutations cause the pleiotropic phenotype of oculodentodigital dysplasia.	American journal of human genetics	2003	143
19338053	2697	Paznekas WA	GJA1 mutations, variants, and connexin 43 dysfunction as it relates to the oculodentodigital dysplasia phenotype.	Human mutation	2009	54
20086076	2697	Mathias RT	Lens gap junctions in growth, differentiation, and homeostasis.	Physiological reviews	2010	69
24434540	2697	Laird DW	Syndromic and non-syndromic disease-linked Cx43 mutations.	FEBS letters	2014	28
9497259	2703	Shiels A	A missense mutation in the human connexin50 gene (GJA8) underlies autosomal dominant "zonular pulverulent" cataract, on chromosome 1q.	American journal of human genetics	1998	102
23035049	3000	Jacobson SG	Determining consequences of retinal membrane guanylyl cyclase (RetGC1) deficiency in human Leber congenital amaurosis en route to therapy: residual cone-photoreceptor vision correlates with biochemical properties of the mutants.	Human molecular genetics	2013	31
15800116	3075	Appel GB	Membranoproliferative glomerulonephritis type II (dense deposit disease): an update.	Journal of the American Society of Nephrology 	2005	72
15870199	3075	Hageman GS	A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration.	Proceedings of the National Academy of Sciences of the United States of America	2005	604
16174643	3075	Rivera A	Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk.	Human molecular genetics	2005	235
17101537	3075	Gehrs KM	Age-related macular degeneration--emerging pathogenetic and therapeutic concepts.	Annals of medicine	2006	141
17339482	3075	Laine M	Y402H polymorphism of complement factor H affects binding affinity to C-reactive protein.	Journal of immunology	2007	80
17399790	3075	Skerka C	Defective complement control of factor H (Y402H) and FHL-1 in age-related macular degeneration.	Molecular immunology	2007	55
17456821	3075	Seddon JM	Association of CFH Y402H and LOC387715 A69S with progression of age-related macular degeneration.	JAMA	2007	91
18054635	3075	Brantley MA Jr	Association of complement factor H and LOC387715 genotypes with response of exudative age-related macular degeneration to intravitreal bevacizumab.	Ophthalmology	2007	56
18081690	3075	de Córdoba SR	Translational mini-review series on complement factor H: genetics and disease associations of human complement factor H.	Clinical and experimental immunology	2008	75
19117936	3075	Seddon JM	Prediction model for prevalence and incidence of advanced age-related macular degeneration based on genetic, demographic, and environmental variables.	Investigative ophthalmology and visual science	2009	101
20660596	3075	Clark SJ	Impaired binding of the age-related macular degeneration-associated complement factor H 402H allotype to Bruch's membrane in human retina.	The Journal of biological chemistry	2010	49
21558292	3075	McKibbin M	CFH, VEGF and HTRA1 promoter genotype may influence the response to intravitreal ranibizumab therapy for neovascular age-related macular degeneration.	The British journal of ophthalmology	2012	31
21959373	3075	Seddon JM	Risk models for progression to advanced age-related macular degeneration using demographic, environmental, genetic, and ocular factors.	Ophthalmology	2011	46
22875704	3075	Shaw PX	Complement factor H genotypes impact risk of age-related macular degeneration by interaction with oxidized phospholipids.	Proceedings of the National Academy of Sciences of the United States of America	2012	34
23337555	3075	Hagstrom SA	Pharmacogenetics for genes associated with age-related macular degeneration in the Comparison of AMD Treatments Trials (CATT).	Ophthalmology	2013	32
23365078	3075	Clark SJ	Tissue-specific host recognition by complement factor H is mediated by differential activities of its glycosaminoglycan-binding regions.	Journal of immunology	2013	34
24084496	3075	Grunwald JE	Risk of geographic atrophy in the comparison of age-related macular degeneration treatments trials.	Ophthalmology	2014	65
25204844	3075	Mullins RF	The membrane attack complex in aging human choriocapillaris: relationship to macular degeneration and choroidal thinning.	The American journal of pathology	2014	22
25140823	3106	Lin P	HLA-B27 and human β2-microglobulin affect the gut microbiota of transgenic rats.	PloS one	2014	28
19118698	3383	Funatsu H	Association of vitreous inflammatory factors with diabetic macular edema.	Ophthalmology	2009	52
23043158	3383	Chen Y	Therapeutic effects of PPARα agonists on diabetic retinopathy in type 1 diabetes models.	Diabetes	2013	27
24335073	3383	Lutty GA	Effects of diabetes on the eye.	Investigative ophthalmology and visual science	2013	26
18391061	3458	Luger D	Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category.	The Journal of experimental medicine	2008	221
19724208	3458	Massingale ML	Analysis of inflammatory cytokines in the tears of dry eye patients.	Cornea	2009	81
21187448	3458	Rajasagi NK	Controlling herpes simplex virus-induced ocular inflammatory lesions with the lipid-derived mediator resolvin E1.	Journal of immunology	2011	44
23592910	3458	Kutty RK	Differential regulation of microRNA-146a and microRNA-146b-5p in human retinal pigment epithelial cells by interleukin-1β, tumor necrosis factor-α, and interferon-γ.	Molecular vision	2013	27
9493273	3552	Rabinowitz YS	Keratoconus.	Survey of ophthalmology	1998	326
9856774	3552	Bradley JM	Effect of matrix metalloproteinases activity on outflow in perfused human organ culture.	Investigative ophthalmology and visual science	1998	109
11527941	3552	Solomon A	Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease.	Investigative ophthalmology and visual science	2001	135
19535655	3552	Fetterman JW Jr	Therapeutic potential of n-3 polyunsaturated fatty acids in disease.	American journal of health-system pharmacy 	2009	45
25056526	3552	Nassar K	Serum cytokines as biomarkers for age-related macular degeneration.	Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie	2015	16
15152078	3553	Mukherjee PK	Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress.	Proceedings of the National Academy of Sciences of the United States of America	2004	185
16202406	3553	Li DQ	JNK and ERK MAP kinases mediate induction of IL-1beta, TNF-alpha and IL-8 following hyperosmolar stress in human limbal epithelial cells.	Experimental eye research	2006	71
16284605	3553	Demircan N	Determination of vitreous interleukin-1 (IL-1) and tumour necrosis factor (TNF) levels in proliferative diabetic retinopathy.	Eye	2006	76
19255163	3553	Chotikavanich S	Production and activity of matrix metalloproteinase-9 on the ocular surface increase in dysfunctional tear syndrome.	Investigative ophthalmology and visual science	2009	69
19997642	3569	Yoshimura T	Comprehensive analysis of inflammatory immune mediators in vitreoretinal diseases.	PloS one	2009	67
22159018	3569	Takai Y	Multiplex cytokine analysis of aqueous humor in eyes with primary open-angle glaucoma, exfoliation glaucoma, and cataract.	Investigative ophthalmology and visual science	2012	34
18037624	4016	Hewitt AW	Ancestral LOXL1 variants are associated with pseudoexfoliation in Caucasian Australians but with markedly lower penetrance than in Nordic people.	Human molecular genetics	2008	66
9005853	4653	Stone EM	Identification of a gene that causes primary open angle glaucoma.	Science	1997	327
10196380	4653	Fingert JH	Analysis of myocilin mutations in 1703 glaucoma patients from five different populations.	Human molecular genetics	1999	134
19554483	4653	Tomarev SI	Olfactomedin domain-containing proteins: possible mechanisms of action and functions in normal development and pathology.	Molecular neurobiology	2009	45
21562585	4653	Fingert JH	Primary open-angle glaucoma genes.	Eye	2011	58
20027112	4763	Jett K	Clinical and genetic aspects of neurofibromatosis 1.	Genetics in medicine 	2010	59
17093405	4901	MacLaren RE	Retinal repair by transplantation of photoreceptor precursors.	Nature	2006	278
18252221	4948	Kayser M	Three genome-wide association studies and a linkage analysis identify HERC2 as a human iris color gene.	American journal of human genetics	2008	55
18252222	4948	Sturm RA	A single SNP in an evolutionary conserved region within intron 86 of the HERC2 gene determines human blue-brown eye color.	American journal of human genetics	2008	85
20157015	4976	Yu-Wai-Man P	Multi-system neurological disease is common in patients with OPA1 mutations.	Brain 	2010	77
17137561	5020	Domes G	Oxytocin improves "mind-reading" in humans.	Biological psychiatry	2007	218
17888410	5020	Guastella AJ	Oxytocin increases gaze to the eye region of human faces.	Biological psychiatry	2008	148
18579733	5020	Petrovic P	Oxytocin attenuates affective evaluations of conditioned faces and amygdala activity.	The Journal of neuroscience 	2008	111
19027101	5020	Ditzen B	Intranasal oxytocin increases positive communication and reduces cortisol levels during couple conflict.	Biological psychiatry	2009	110
19632787	5020	Domes G	Effects of intranasal oxytocin on emotional face processing in women.	Psychoneuroendocrinology	2010	120
20047458	5020	Macdonald K	The peptide that binds: a systematic review of oxytocin and its prosocial effects in humans.	Harvard review of psychiatry	2010	78
20421469	5020	Gamer M	Different amygdala subregions mediate valence-related and attentional effects of oxytocin in humans.	Proceedings of the National Academy of Sciences of the United States of America	2010	105
22365820	5020	Lischke A	Oxytocin increases amygdala reactivity to threatening scenes in females.	Psychoneuroendocrinology	2012	43
23510581	5020	Domes G	Effects of intranasal oxytocin on the neural basis of face processing in autism spectrum disorder.	Biological psychiatry	2013	43
7951315	5080	Glaser T	PAX6 gene dosage effect in a family with congenital cataracts, aniridia, anophthalmia and central nervous system defects.	Nature genetics	1994	168
11069887	5080	Ashery-Padan R	Pax6 activity in the lens primordium is required for lens formation and for correct placement of a single retina in the eye.	Genes and development	2000	209
15057935	5080	Cvekl A	Anterior eye development and ocular mesenchyme: new insights from mouse models and human diseases.	BioEssays 	2004	78
20621053	5080	Zhang X	Pax6 is a human neuroectoderm cell fate determinant.	Cell stem cell	2010	96
20691855	5080	Graw J	Eye development.	Current topics in developmental biology	2010	44
23643363	5080	Tuoc TC	Chromatin regulation by BAF170 controls cerebral cortical size and thickness.	Developmental cell	2013	40
24902832	5080	Gehring WJ	The evolution of vision.	Wiley interdisciplinary reviews. Developmental biology	2014	22
25030175	5080	Ouyang H	WNT7A and PAX6 define corneal epithelium homeostasis and pathogenesis.	Nature	2014	28
26958831	5080	Lin H	Lens regeneration using endogenous stem cells with gain of visual function.	Nature	2016	13
14975938	5176	Bard MP	Proteomic analysis of exosomes isolated from human malignant pleural effusions.	American journal of respiratory cell and molecular biology	2004	85
16019000	5176	Bhutto IA	Pigment epithelium-derived factor (PEDF) and vascular endothelial growth factor (VEGF) in aged human choroid and eyes with age-related macular degeneration.	Experimental eye research	2006	77
16454650	5176	Campochiaro PA	Adenoviral vector-delivered pigment epithelium-derived factor for neovascular age-related macular degeneration: results of a phase I clinical trial.	Human gene therapy	2006	73
16877436	5176	Maminishkis A	Confluent monolayers of cultured human fetal retinal pigment epithelium exhibit morphology and physiology of native tissue.	Investigative ophthalmology and visual science	2006	123
21353196	5176	Becker J	Exome sequencing identifies truncating mutations in human SERPINF1 in autosomal-recessive osteogenesis imperfecta.	American journal of human genetics	2011	82
21364903	5176	Vaajasaari H	Toward the defined and xeno-free differentiation of functional human pluripotent stem cell-derived retinal pigment epithelial cells.	Molecular vision	2011	37
21826736	5176	Homan EP	Mutations in SERPINF1 cause osteogenesis imperfecta type VI.	Journal of bone and mineral research 	2011	36
21960553	5176	Ablonczy Z	Human retinal pigment epithelium cells as functional models for the RPE in vivo.	Investigative ophthalmology and visual science	2011	51
15005199	5362	Nassif N	In vivo human retinal imaging by ultrahigh-speed spectral domain optical coherence tomography.	Optics letters	2004	96
18795054	5362	Potsaid B	Ultrahigh speed spectral / Fourier domain OCT ophthalmic imaging at 70,000 to 312,500 axial scans per second.	Optics express	2008	104
19293916	5362	Grulkowski I	Anterior segment imaging with Spectral OCT system using a high-speed CMOS camera.	Optics express	2009	48
19546917	5362	Yasuno Y	In vivo high-contrast imaging of deep posterior eye by 1-microm swept source optical coherence tomography and scattering optical coherence angiography.	Optics express	2007	80
20445110	5362	Esmaeelpour M	Three-dimensional 1060-nm OCT: choroidal thickness maps in normal subjects and improved posterior segment visualization in cataract patients.	Investigative ophthalmology and visual science	2010	43
20920824	5362	Mwanza JC	Ability of cirrus HD-OCT optic nerve head parameters to discriminate normal from glaucomatous eyes.	Ophthalmology	2011	49
21263663	5362	Zotter S	Visualization of microvasculature by dual-beam phase-resolved Doppler optical coherence tomography.	Optics express	2011	45
22418228	5362	Jia Y	Split-spectrum amplitude-decorrelation angiography with optical coherence tomography.	Optics express	2012	186
24845642	5362	Wilk MA	Relationship between foveal cone specialization and pit morphology in albinism.	Investigative ophthalmology and visual science	2014	24
25230403	5362	Huang Y	Swept-source OCT angiography of the retinal vasculature using intensity differentiation-based optical microangiography algorithms.	Ophthalmic surgery, lasers and imaging retina	2014	36
25423628	5362	Moult E	Ultrahigh-speed swept-source OCT angiography in exudative AMD.	Ophthalmic surgery, lasers and imaging retina	2014	23
26255817	5362	Wang X	Correlation between optic disc perfusion and glaucomatous severity in patients with open-angle glaucoma: an optical coherence tomography angiography study.	Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie	2015	33
26393725	5362	Gao SS	Optimization of the split-spectrum amplitude-decorrelation angiography algorithm on a spectral optical coherence tomography system.	Optics letters	2015	28
26457396	5362	Takase N	ENLARGEMENT OF FOVEAL AVASCULAR ZONE IN DIABETIC EYES EVALUATED BY EN FACE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY.	Retina	2015	19
26491548	5362	Mastropasqua R	Optical Coherence Tomography Angiography in Retinal Vascular Diseases and Choroidal Neovascularization.	Journal of ophthalmology	2015	17
26912261	5362	Zhang Q	Wide-field optical coherence tomography based microangiography for retinal imaging.	Scientific reports	2016	14
17467529	5460	Parikh RS	Normal age-related decay of retinal nerve fiber layer thickness.	Ophthalmology	2007	56
24296783	5460	Zhu S	Small molecules enable OCT4-mediated direct reprogramming into expandable human neural stem cells.	Cell research	2014	22
2537532	5925	Dyson N	The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product.	Science	1989	700
2673546	5925	Chen PL	Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation.	Cell	1989	215
25252974	5925	Xu XL	Rb suppresses human cone-precursor-derived retinoblastoma tumours.	Nature	2014	24
20098701	5949	Lamba DA	Generation, purification and transplantation of photoreceptors derived from human induced pluripotent stem cells.	PloS one	2010	115
8202715	5961	Kajiwara K	Digenic retinitis pigmentosa due to mutations at the unlinked peripherin/RDS and ROM1 loci.	Science	1994	151
21347327	5961	Jin ZB	Modeling retinal degeneration using patient-specific induced pluripotent stem cells.	PloS one	2011	68
2137202	6010	Dryja TP	A point mutation of the rhodopsin gene in one form of retinitis pigmentosa.	Nature	1990	212
2937147	6010	Nathans J	Molecular genetics of human color vision: the genes encoding blue, green, and red pigments.	Science	1986	225
9701253	6010	Lewin AS	Ribozyme rescue of photoreceptor cells in a transgenic rat model of autosomal dominant retinitis pigmentosa.	Nature medicine	1998	100
12634111	6010	Gupta N	Activated microglia in human retinitis pigmentosa, late-onset retinal degeneration, and age-related macular degeneration.	Experimental eye research	2003	135
12866125	6010	Jones BW	Retinal remodeling triggered by photoreceptor degenerations.	The Journal of comparative neurology	2003	118
15177205	6010	Lamb TD	Dark adaptation and the retinoid cycle of vision.	Progress in retinal and eye research	2004	180
17591900	6010	Duncan JL	High-resolution imaging with adaptive optics in patients with inherited retinal degeneration.	Investigative ophthalmology and visual science	2007	99
17693260	6010	Chuang JZ	SARA-regulated vesicular targeting underlies formation of the light-sensing organelle in mammalian rods.	Cell	2007	72
19084410	6010	Okawa H	ATP consumption by mammalian rod photoreceptors in darkness and in light.	Current biology 	2008	72
22074921	6010	Palczewski K	Chemistry and biology of vision.	The Journal of biological chemistry	2012	76
23129659	6010	Kwasnieski JC	Complex effects of nucleotide variants in a mammalian cis-regulatory element.	Proceedings of the National Academy of Sciences of the United States of America	2012	56
23139242	6010	Singh R	iPS cell modeling of Best disease: insights into the pathophysiology of an inherited macular degeneration.	Human molecular genetics	2013	68
24135424	6010	Wang J	Molecular complexes that direct rhodopsin transport to primary cilia.	Progress in retinal and eye research	2014	38
8698076	6017	Dunn KC	ARPE-19, a human retinal pigment epithelial cell line with differentiated properties.	Experimental eye research	1996	294
18483561	6017	Marc RE	Extreme retinal remodeling triggered by light damage: implications for age related macular degeneration.	Molecular vision	2008	70
18376416	6102	Veltel S	The retinitis pigmentosa 2 gene product is a GTPase-activating protein for Arf-like 3.	Nature structural and molecular biology	2008	50
23150612	6102	Branham K	Mutations in RPGR and RP2 account for 15% of males with simplex retinal degenerative disease.	Investigative ophthalmology and visual science	2012	33
15723066	6103	Otto EA	Nephrocystin-5, a ciliary IQ domain protein, is mutated in Senior-Loken syndrome and interacts with RPGR and calmodulin.	Nature genetics	2005	126
26814166	6103	Bassuk AG	Precision Medicine: Genetic Repair of Retinitis Pigmentosa in Patient-Derived Stem Cells.	Scientific reports	2016	16
9326941	6121	Gu SM	Mutations in RPE65 cause autosomal recessive childhood-onset severe retinal dystrophy.	Nature genetics	1997	145
9501220	6121	Morimura H	Mutations in the RPE65 gene in patients with autosomal recessive retinitis pigmentosa or leber congenital amaurosis.	Proceedings of the National Academy of Sciences of the United States of America	1998	102
17848510	6121	Jacobson SG	Human cone photoreceptor dependence on RPE65 isomerase.	Proceedings of the National Academy of Sciences of the United States of America	2007	61
18441370	6121	Maguire AM	Safety and efficacy of gene transfer for Leber's congenital amaurosis.	The New England journal of medicine	2008	681
18441371	6121	Bainbridge JW	Effect of gene therapy on visual function in Leber's congenital amaurosis.	The New England journal of medicine	2008	601
18774912	6121	Hauswirth WW	Treatment of leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial.	Human gene therapy	2008	340
18809924	6121	Cideciyan AV	Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics.	Proceedings of the National Academy of Sciences of the United States of America	2008	271
19583479	6121	Cideciyan AV	Human RPE65 gene therapy for Leber congenital amaurosis: persistence of early visual improvements and safety at 1 year.	Human gene therapy	2009	119
19854499	6121	Maguire AM	Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial.	Lancet	2009	245
19953081	6121	Simonelli F	Gene therapy for Leber's congenital amaurosis is safe and effective through 1.5 years after vector administration.	Molecular therapy 	2010	179
20399883	6121	Cideciyan AV	Leber congenital amaurosis due to RPE65 mutations and its treatment with gene therapy.	Progress in retinal and eye research	2010	69
20811160	6121	den Hollander AI	Lighting a candle in the dark: advances in genetics and gene therapy of recessive retinal dystrophies.	The Journal of clinical investigation	2010	68
21606598	6121	Ashtari M	The human visual cortex responds to gene therapy-mediated recovery of retinal function.	The Journal of clinical investigation	2011	45
21654732	6121	Bowne SJ	A dominant mutation in RPE65 identified by whole-exome sequencing causes retinitis pigmentosa with choroidal involvement.	European journal of human genetics 	2011	41
21911650	6121	Jacobson SG	Gene therapy for leber congenital amaurosis caused by RPE65 mutations: safety and efficacy in 15 children and adults followed up to 3 years.	Archives of ophthalmology	2012	170
23474247	6121	Testa F	Three-year follow-up after unilateral subretinal delivery of adeno-associated virus in patients with Leber congenital Amaurosis type 2.	Ophthalmology	2013	77
25635059	6121	Pierce EA	The Status of RPE65 Gene Therapy Trials: Safety and Efficacy.	Cold Spring Harbor perspectives in medicine	2015	21
27375040	6121	Bennett J	Safety and durability of effect of contralateral-eye administration of AAV2 gene therapy in patients with childhood-onset blindness caused by RPE65 mutations: a follow-on phase 1 trial.	Lancet	2016	20
11102475	7124	Tezel G	Increased production of tumor necrosis factor-alpha by glial cells exposed to simulated ischemia or elevated hydrostatic pressure induces apoptosis in cocultured retinal ganglion cells.	The Journal of neuroscience 	2000	92
17589522	7124	Connor KM	Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis.	Nature medicine	2007	189
18029267	7124	Gupta V	Intraocular tuberculosis--an update.	Survey of ophthalmology	2007	79
20664046	7124	Ramos-Casals M	Treatment of primary Sjögren syndrome: a systematic review.	JAMA	2010	46
21252670	7124	Danesh-Meyer HV	Neuroprotection in glaucoma: recent and future directions.	Current opinion in ophthalmology	2011	37
21917936	7124	Yang X	Neurodegenerative and inflammatory pathway components linked to TNF-α/TNFR1 signaling in the glaucomatous human retina.	Investigative ophthalmology and visual science	2011	37
26154136	7124	Vavricka SR	Extraintestinal Manifestations of Inflammatory Bowel Disease.	Inflammatory bowel diseases	2015	16
7526212	7422	Aiello LP	Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.	The New England journal of medicine	1994	569
10406801	7422	Asahara T	VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells.	The EMBO journal	1999	299
12941734	7422	Ciulla TA	Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapies.	Diabetes care	2003	94
15625332	7422	Gragoudas ES	Pegaptanib for neovascular age-related macular degeneration.	The New England journal of medicine	2004	368
16154196	7422	Cunningham ET Jr	A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema.	Ophthalmology	2005	106
16193288	7422	Perrin RM	Diabetic retinopathy is associated with a switch in splicing from anti- to pro-angiogenic isoforms of vascular endothelial growth factor.	Diabetologia	2005	70
16518379	7422	Ng EW	Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease.	Nature reviews. Drug discovery	2006	206
17046701	7422	Nguyen QD	Vascular endothelial growth factor is a critical stimulus for diabetic macular edema.	American journal of ophthalmology	2006	69
17591953	7422	Nishijima K	Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury.	The American journal of pathology	2007	170
17674014	7422	Wu L	Twelve-month safety of intravitreal injections of bevacizumab (Avastin): results of the Pan-American Collaborative Retina Study Group (PACORES).	Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie	2008	72
18163003	7422	Andreoli CM	Anti-vascular endothelial growth factor therapy for ocular neovascular disease.	Current opinion in ophthalmology	2007	59
18293182	7422	Rehak J	Branch retinal vein occlusion: pathogenesis, visual prognosis, and treatment modalities.	Current eye research	2008	58
18362932	7422	Campochiaro PA	Ranibizumab for macular edema due to retinal vein occlusions: implication of VEGF as a critical stimulator.	Molecular therapy 	2008	61
18653375	7422	Penn JS	Vascular endothelial growth factor in eye disease.	Progress in retinal and eye research	2008	132
19854291	7422	Laude A	Polypoidal choroidal vasculopathy and neovascular age-related macular degeneration: same or different disease?	Progress in retinal and eye research	2010	46
20811159	7422	Bird AC	Therapeutic targets in age-related macular disease.	The Journal of clinical investigation	2010	58
21264342	7422	Rymo SF	A two-way communication between microglial cells and angiogenic sprouts regulates angiogenesis in aortic ring cultures.	PloS one	2011	39
21323540	7422	Mintz-Hittner HA	Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity.	The New England journal of medicine	2011	124
21527770	7422	Rini BI	Hypertension as a biomarker of efficacy in patients with metastatic renal cell carcinoma treated with sunitinib.	Journal of the National Cancer Institute	2011	115
21529957	7422	Sultan MB	A phase 2/3, multicenter, randomized, double-masked, 2-year trial of pegaptanib sodium for the treatment of diabetic macular edema.	Ophthalmology	2011	38
21546089	7422	Do DV	The DA VINCI Study: phase 2 primary results of VEGF Trap-Eye in patients with diabetic macular edema.	Ophthalmology	2011	55
21593862	7422	Carmeliet P	Molecular mechanisms and clinical applications of angiogenesis.	Nature	2011	810
21708378	7422	Manjunath V	Analysis of choroidal thickness in age-related macular degeneration using spectral-domain optical coherence tomography.	American journal of ophthalmology	2011	36
21930258	7422	Sato T	Serum concentrations of bevacizumab (avastin) and vascular endothelial growth factor in infants with retinopathy of prematurity.	American journal of ophthalmology	2012	42
22212972	7422	Stewart MW	The expanding role of vascular endothelial growth factor inhibitors in ophthalmology.	Mayo Clinic proceedings	2012	33
22264944	7422	Bloch SB	Incidence of legal blindness from age-related macular degeneration in denmark: year 2000 to 2010.	American journal of ophthalmology	2012	35
22301066	7422	Heier JS	Ranibizumab for macular edema due to retinal vein occlusions: long-term follow-up in the HORIZON trial.	Ophthalmology	2012	55
22330964	7422	Nguyen QD	Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE.	Ophthalmology	2012	171
22374154	7422	Stewart MW	Pharmacokinetic rationale for dosing every 2 weeks versus 4 weeks with intravitreal ranibizumab, bevacizumab, and aflibercept (vascular endothelial growth factor Trap-eye).	Retina	2012	41
22399811	7422	dela Paz NG	Role of shear-stress-induced VEGF expression in endothelial cell survival.	Journal of cell science	2012	37
22537617	7422	Do DV	One-year outcomes of the da Vinci Study of VEGF Trap-Eye in eyes with diabetic macular edema.	Ophthalmology	2012	64
22555112	7422	Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group.	Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results.	Ophthalmology	2012	294
22578446	7422	IVAN Study Investigators.	Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial.	Ophthalmology	2012	144
23084240	7422	Heier JS	Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration.	Ophthalmology	2012	192
23218699	7422	Brown DM	Intravitreal aflibercept injection for macular edema secondary to central retinal vein occlusion: 1-year results from the phase 3 COPERNICUS study.	American journal of ophthalmology	2013	36
23438028	7422	Durand ML	Endophthalmitis.	Clinical microbiology and infection 	2013	40
23549101	7422	Kumar N	Visual and anatomical outcomes of intravitreal aflibercept in eyes with persistent subfoveal fluid despite previous treatments with ranibizumab in patients with neovascular age-related macular degeneration.	Retina	2013	35
23585288	7422	Maruotti J	A simple and scalable process for the differentiation of retinal pigment epithelium from human pluripotent stem cells.	Stem cells translational medicine	2013	26
23642377	7422	Jaffe GJ	Macular morphology and visual acuity in the comparison of age-related macular degeneration treatments trials.	Ophthalmology	2013	26
23642784	7422	Haller JA	Current anti-vascular endothelial growth factor dosing regimens: benefits and burden.	Ophthalmology	2013	27
23642856	7422	Rofagha S	Seven-year outcomes in ranibizumab-treated patients in ANCHOR, MARINA, and HORIZON: a multicenter cohort study (SEVEN-UP).	Ophthalmology	2013	111
23664153	7422	Ho VY	Short-term outcomes of aflibercept for neovascular age-related macular degeneration in eyes previously treated with other vascular endothelial growth factor inhibitors.	American journal of ophthalmology	2013	35
23706949	7422	Brown DM	Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE.	Ophthalmology	2013	85
23908119	7422	Welti J	Recent molecular discoveries in angiogenesis and antiangiogenic therapies in cancer.	The Journal of clinical investigation	2013	102
24335072	7422	Bowes Rickman C	Dry age-related macular degeneration: mechanisms, therapeutic targets, and imaging.	Investigative ophthalmology and visual science	2013	37
24525867	7422	Osaadon P	A review of anti-VEGF agents for proliferative diabetic retinopathy.	Eye	2014	23
24673341	7422	Abcouwer SF	Diabetic retinopathy: loss of neuroretinal adaptation to the diabetic metabolic environment.	Annals of the New York Academy of Sciences	2014	24
25001321	7422	Avery RL	Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMD.	The British journal of ophthalmology	2014	24
25012934	7422	Korobelnik JF	Intravitreal aflibercept for diabetic macular edema.	Ophthalmology	2014	56
25136079	7422	Schmidt-Erfurth U	Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA).	The British journal of ophthalmology	2014	26
25170575	7422	Solomon SD	Anti-vascular endothelial growth factor for neovascular age-related macular degeneration.	The Cochrane database of systematic reviews	2014	39
25193672	7422	Holz FG	Multi-country real-life experience of anti-vascular endothelial growth factor therapy for wet age-related macular degeneration.	The British journal of ophthalmology	2015	22
25342124	7422	Virgili G	Anti-vascular endothelial growth factor for diabetic macular oedema.	The Cochrane database of systematic reviews	2014	30
25444347	7422	Hartnett ME	Pathophysiology and mechanisms of severe retinopathy of prematurity.	Ophthalmology	2015	25
25542520	7422	Grunwald JE	Growth of geographic atrophy in the comparison of age-related macular degeneration treatments trials.	Ophthalmology	2015	31
25887628	7422	Spaide RF	Optical Coherence Tomography Angiography Signs of Vascular Abnormalization With Antiangiogenic Therapy for Choroidal Neovascularization.	American journal of ophthalmology	2015	20
25896459	7422	Ishibazawa A	Optical Coherence Tomography Angiography in Diabetic Retinopathy: A Prospective Pilot Study.	American journal of ophthalmology	2015	50
26113213	7422	Nazari H	Stem cell based therapies for age-related macular degeneration: The promises and the challenges.	Progress in retinal and eye research	2015	19
26164826	7422	Kuehlewein L	Optical Coherence Tomography Angiography of Type 1 Neovascularization in Age-Related Macular Degeneration.	American journal of ophthalmology	2015	26
26431823	7422	Rakoczy EP	Gene therapy with recombinant adeno-associated vectors for neovascular age-related macular degeneration: 1 year follow-up of a phase 1 randomised clinical trial.	Lancet	2015	19
26935357	7422	Wells JA	Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema: Two-Year Results from a Comparative Effectiveness Randomized Clinical Trial.	Ophthalmology	2016	26
27156698	7422	Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group.	Five-Year Outcomes with Anti-Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration: The Comparison of Age-Related Macular Degeneration Treatments Trials.	Ophthalmology	2016	16
11050159	7439	Marmorstein AD	Bestrophin, the product of the Best vitelliform macular dystrophy gene (VMD2), localizes to the basolateral plasma membrane of the retinal pigment epithelium.	Proceedings of the National Academy of Sciences of the United States of America	2000	102
16282372	7439	Rosenthal R	Expression of bestrophin-1, the product of the VMD2 gene, modulates voltage-dependent Ca2+ channels in retinal pigment epithelial cells.	FASEB journal 	2006	66
18179881	7439	Burgess R	Biallelic mutation of BEST1 causes a distinct retinopathy in humans.	American journal of human genetics	2008	61
18391176	7439	Hartzell HC	Molecular physiology of bestrophins: multifunctional membrane proteins linked to best disease and other retinopathies.	Physiological reviews	2008	100
19375515	7439	Boon CJ	The spectrum of ocular phenotypes caused by mutations in the BEST1 gene.	Progress in retinal and eye research	2009	52
19853238	7439	Davidson AE	Missense mutations in a retinal pigment epithelium protein, bestrophin-1, cause retinitis pigmentosa.	American journal of human genetics	2009	46
16140383	8266	Wojtkowski M	Three-dimensional retinal imaging with high-speed ultrahigh-resolution optical coherence tomography.	Ophthalmology	2005	155
11248048	8626	Pellegrini G	p63 identifies keratinocyte stem cells.	Proceedings of the National Academy of Sciences of the United States of America	2001	257
15983386	8626	Di Iorio E	Isoforms of DeltaNp63 and the migration of ocular limbal cells in human corneal regeneration.	Proceedings of the National Academy of Sciences of the United States of America	2005	73
20573916	8626	Rama P	Limbal stem-cell therapy and long-term corneal regeneration.	The New England journal of medicine	2010	177
10655056	10002	Haider NB	Mutation of a nuclear receptor gene, NR2E3, causes enhanced S cone syndrome, a disorder of retinal cell fate.	Nature genetics	2000	122
15190009	10002	Cheng H	Photoreceptor-specific nuclear receptor NR2E3 functions as a transcriptional activator in rod photoreceptors.	Human molecular genetics	2004	88
15689355	10002	Peng GH	The photoreceptor-specific nuclear receptor Nr2e3 interacts with Crx and exerts opposing effects on the transcription of rod versus cone genes.	Human molecular genetics	2005	88
17653270	10002	Hsiau TH	The cis-regulatory logic of the mammalian photoreceptor transcriptional network.	PloS one	2007	65
17662965	10002	Hennig AK	Regulation of photoreceptor gene expression by Crx-associated transcription factor network.	Brain research	2008	66
20648062	10002	Swaroop A	Transcriptional regulation of photoreceptor development and homeostasis in the mammalian retina.	Nature reviews. Neuroscience	2010	138
26235913	10002	Kaewkhaw R	Transcriptome Dynamics of Developing Photoreceptors in Three-Dimensional Retina Cultures Recapitulates Temporal Sequence of Human Cone and Rod Differentiation Revealing Cell Surface Markers and Gene Networks.	Stem cells	2015	18
16723467	10133	Abu-Amero KK	Mitochondrial abnormalities in patients with primary open-angle glaucoma.	Investigative ophthalmology and visual science	2006	74
23669351	10133	Minegishi Y	Enhanced optineurin E50K-TBK1 interaction evokes protein insolubility and initiates familial primary open-angle glaucoma.	Human molecular genetics	2013	30
16051216	10242	Schlötzer-Schrehardt U	Identification and characterization of limbal stem cells.	Experimental eye research	2005	95
11062461	10461	Gal A	Mutations in MERTK, the human orthologue of the RCS rat retinal dystrophy gene, cause retinitis pigmentosa.	Nature genetics	2000	171
19204785	10461	Carr AJ	Molecular characterization and functional analysis of phagocytosis by human embryonic stem cell-derived RPE cells using a novel human retinal assay.	Molecular vision	2009	53
26825853	10461	Ghazi NG	Treatment of retinitis pigmentosa due to MERTK mutations by ocular subretinal injection of adeno-associated virus gene vector: results of a phase I trial.	Human genetics	2016	20
12369018	10585	Beltrán-Valero de Bernabé D	Mutations in the O-mannosyltransferase gene POMT1 give rise to the severe neuronal migration disorder Walker-Warburg syndrome.	American journal of human genetics	2002	134
17878207	10585	Godfrey C	Refining genotype phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan.	Brain 	2007	97
2324310	10687	Curcio CA	Human photoreceptor topography.	The Journal of comparative neurology	1990	374
15371438	11168	Cherepanov P	Identification of an evolutionarily conserved domain in human lens epithelium-derived growth factor/transcriptional co-activator p75 (LEDGF/p75) that binds HIV-1 integrase.	The Journal of biological chemistry	2004	113
15895093	11168	Cherepanov P	Solution structure of the HIV-1 integrase-binding domain in LEDGF/p75.	Nature structural and molecular biology	2005	92
10508521	23418	den Hollander AI	Mutations in a human homologue of Drosophila crumbs cause retinitis pigmentosa (RP12).	Nature genetics	1999	108
11850625	23418	Pellikka M	Crumbs, the Drosophila homologue of human CRB1/RP12, is essential for photoreceptor morphogenesis.	Nature	2002	111
11927608	23418	Roh MH	The Maguk protein, Pals1, functions as an adapter, linking mammalian homologues of Crumbs and Discs Lost.	The Journal of cell biology	2002	85
15024725	23418	Hanein S	Leber congenital amaurosis: comprehensive survey of the genetic heterogeneity, refinement of the clinical definition, and genotype-phenotype correlations as a strategy for molecular diagnosis.	Human mutation	2004	94
22065545	23418	Bujakowska K	CRB1 mutations in inherited retinal dystrophies.	Human mutation	2012	32
18632300	23746	den Hollander AI	Leber congenital amaurosis: genes, proteins and disease mechanisms.	Progress in retinal and eye research	2008	215
19251738	55636	Schnetz MP	Genomic distribution of CHD7 on chromatin tracks H3K4 methylation patterns.	Genome research	2009	77
20186815	55636	Zentner GE	Molecular and phenotypic aspects of CHD7 mutation in CHARGE syndrome.	American journal of medical genetics. Part A	2010	57
21378379	55636	Bergman JE	CHD7 mutations and CHARGE syndrome: the clinical implications of an expanding phenotype.	Journal of medical genetics	2011	42
22461308	55636	Janssen N	Mutation update on the CHD7 gene involved in CHARGE syndrome.	Human mutation	2012	48
23215558	55636	Talkowski ME	Clinical diagnosis by whole-genome sequencing of a prenatal sample.	The New England journal of medicine	2012	37
24211491	55636	Tahara T	Colorectal carcinomas with CpG island methylator phenotype 1 frequently contain mutations in chromatin regulators.	Gastroenterology	2014	21
18443312	80025	McNeill A	T2* and FSE MRI distinguishes four subtypes of neurodegeneration with brain iron accumulation.	Neurology	2008	51
23474058	80025	Boeve BF	Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder.	Sleep medicine	2013	34
12522249	94233	Lucas RJ	Diminished pupillary light reflex at high irradiances in melanopsin-knockout mice.	Science	2003	184
12808468	94233	Hattar S	Melanopsin and rod-cone photoreceptive systems account for all major accessory visual functions in mice.	Nature	2003	270
17320141	94233	Gamlin PD	Human and macaque pupil responses driven by melanopsin-containing retinal ganglion cells.	Vision research	2007	98
18054803	94233	Hankins MW	Melanopsin: an exciting photopigment.	Trends in neurosciences	2008	64
18836071	94233	Lin B	Restoration of visual function in retinal degeneration mice by ectopic expression of melanopsin.	Proceedings of the National Academy of Sciences of the United States of America	2008	74
19850061	94233	McDougal DH	The influence of intrinsically-photosensitive retinal ganglion cells on the spectral sensitivity and response dynamics of the human pupillary light reflex.	Vision research	2010	49
20463367	94233	Gooley JJ	Spectral responses of the human circadian system depend on the irradiance and duration of exposure to light.	Science translational medicine	2010	52
20471354	94233	Lall GS	Distinct contributions of rod, cone, and melanopsin photoreceptors to encoding irradiance.	Neuron	2010	78
20959623	94233	Do MT	Intrinsically photosensitive retinal ganglion cells.	Physiological reviews	2010	81
21151887	94233	Brown TM	Melanopsin contributions to irradiance coding in the thalamo-cortical visual system.	PLoS biology	2010	68
21743008	94233	Park JC	Toward a clinical protocol for assessing rod, cone, and melanopsin contributions to the human pupil response.	Investigative ophthalmology and visual science	2011	40
21816493	94233	Schmidt TM	Intrinsically photosensitive retinal ganglion cells: many subtypes, diverse functions.	Trends in neurosciences	2011	87
22633808	94233	Brown TM	Melanopsin-based brightness discrimination in mice and humans.	Current biology 	2012	36
22895730	94233	Wong KY	A retinal ganglion cell that can signal irradiance continuously for 10 hours.	The Journal of neuroscience 	2012	32
23554393	94233	Bailes HJ	Human melanopsin forms a pigment maximally sensitive to blue light (λmax ≈ 479 nm) supporting activation of G(q/11) and G(i/o) signalling cascades.	Proceedings. Biological sciences	2013	32
26505992	94233	La Morgia C	Melanopsin retinal ganglion cell loss in Alzheimer disease.	Annals of neurology	2016	16
22310372	114548	Demb JB	Intrinsic properties and functional circuitry of the AII amacrine cell.	Visual neuroscience	2012	43
22541070	114548	Tarallo V	DICER1 loss and Alu RNA induce age-related macular degeneration via the NLRP3 inflammasome and MyD88.	Cell	2012	149
23221073	114548	Tseng WA	NLRP3 inflammasome activation in retinal pigment epithelial cells by lysosomal destabilization: implications for age-related macular degeneration.	Investigative ophthalmology and visual science	2013	59
26877061	114548	Karmakar M	Neutrophil P2X7 receptors mediate NLRP3 inflammasome-dependent IL-1β secretion in response to ATP.	Nature communications	2016	23
17952075	123041	Sulem P	Genetic determinants of hair, eye and skin pigmentation in Europeans.	Nature genetics	2007	180
18483556	123041	Han J	A genome-wide association study identifies novel alleles associated with hair color and skin pigmentation.	PLoS genetics	2008	125
19297406	123041	Sturm RA	Molecular genetics of human pigmentation diversity.	Human molecular genetics	2009	80
19710684	123041	Duffy DL	Multiple pigmentation gene polymorphisms account for a substantial proportion of risk of cutaneous malignant melanoma.	The Journal of investigative dermatology	2010	51
20585627	123041	Eriksson N	Web-based, participant-driven studies yield novel genetic associations for common traits.	PLoS genetics	2010	104
20395239	220202	Macgregor S	Genome-wide association identifies ATOH7 as a major gene determining human optic disc size.	Human molecular genetics	2010	48
21441919	220202	Ghiasvand NM	Deletion of a remote enhancer near ATOH7 disrupts retinal neurogenesis, causing NCRNA disease.	Nature neuroscience	2011	40
17884985	387715	Kanda A	A variant of mitochondrial protein LOC387715/ARMS2, not HTRA1, is strongly associated with age-related macular degeneration.	Proceedings of the National Academy of Sciences of the United States of America	2007	139
24497574	387715	Yang J	Validation of genome-wide association study (GWAS)-identified disease risk alleles with patient-specific stem cell lines.	Human molecular genetics	2014	21
9836530	100506658	Antonetti DA	Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group.	Diabetes	1998	115
